Human Health and Heredity in Africa: Research Grants Program
Page 2

The Human Health and Heredity in Africa: Research Grants Program was initially created to address the concerns of low and middle-income nations who are having the difficulty to safeguard and sustain the health and well-being of its people.

The target counties often face the burden of having to deal with various health conditions such as infectious diseases, malnutrition, and a growing number of chronic diseases.

The project aims to address this concerns by focusing the scope of the research studies in the following areas:

1) Genetic/environmental contributors to non-communicable disease in Africa

2) Genetic/environmental contributors to communicable disease in Africa

3) Contribution of the human microbiome to health and disease in Africa

4) The occurence of Mendelian diseases in Africa

5) The field of Pharmacogenics

The National Institutes of Health is set to administer a total funding amount of $1.25 million per year, which can last up to four years.

The institutions and organizations that are eligible to submit an application under Human Health and Heredity in Africa: Research Grants Program are the following:

a) Non-domestic (non-U.S.) Entities (African Institutions) such as African institutions, Public/State Controlled Institutions of Higher Education, and Private Institutions of Higher Education

b) Non domestic foreign institutions.

Human Health and Heredity in Africa: Research Grants Program
  Back to Page 1

About The Author Michael Saunders is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. He also maintains Websites providing resources on artist grants and children grants.

Additional Resources

category - Health Grants

HIV Innovations for Improved Patient Outcomes for Priority Populations Program
The United States Agency for International Development in South Africa has recently established the HIV Innovations for Improved Patient Outcomes for Priority Populations Program wherein it intends to solicit applications coming from local organizations which are interested in heading the implementation of a five-year plan centered on the program in focus.

---

Research to Advance Vaccine Safety Program
The Centers for Disease Control and Prevention has partnered with the National Institutes of Health and as a result, has developed the Research to Advance Vaccine Safety Program, wherein it seeks to obtain a more thorough understanding vaccine safety.

---

Strategic Alliances for Medications Development to Treat Substance Use Disorder Program
The National Institutes of Health, in cooperation with the National Institute on Drug Abuse (NIDA), has recently established the Strategic Alliances for Medications Development to Treat Substance Use Disorder Program wherein both agencies seek to support the development of substance abuse drugs by leveraging the strengths of two or more organizations toward a common goal of medications development.

---

Core Clinical Centers for the Cardiothoracic Surgical Trials Network Program
In keeping with this mission, the National Institutes of Health has partnered with the Canadian Institutes of Health Research (CIHR), the National Heart, Lung, and Blood Institute (NHLBI), and the Institute of Circulatory and Respiratory Health (ICRH) to establish the Core Clinical Centers for the Cardiothoracic Surgical Trials Network Program.

---